Most women are unaware that their bones reach their maximum strength by about thirty years of age.

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

Dr Reddy's Laboratories Ltd (RDY) reports steady revenue growth driven by emerging markets and strategic collaborations, ...

Gireesh Babu, New Delhi Wednesday, January 21, 2026, 08:00 Hrs [IST] ...

In its first financial results announcement after the spin-off, Samsung Bioepis recorded FY2025 revenue of KRW 1.672 trillion, highest annual revenue in its 14-year history Excluding milestone ...

Amgen reported early Phase 2 data suggesting patients kept weight off with less frequent dosing, a potential differentiator ...

The primary cause of osteoporosis is a change in the bone’s structure. Osteoporosis is a bone disease that occurs when your bone mass decreases, leading to an increased risk of fractures, or broken ...

Denosumab is indicated for treating osteoporosis in postmenopausal women, preventing skeletal-related complications in cancer ...

Every year style and beauty evolve in exciting new directions. We met Ramani Fernando, one of Sri Lanka’s most celebrated ...

More than three decades after it first illuminated a Colombo stage, Chekhov Sandhyava returns—not as a relic revived for ...

Amneal Pharmaceuticals re c eived FDA approval for two denosumab biosimilars referencing Prolia and Xgeva. The approval, announced Dec. 22, covers Boncresa (denosumab-mobz) and Oziltus (denosumab-mobz ...

Ondibta is approved for the treatment of diabetes mellitus in adults, adolescents and in children aged two years old and ...